Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT02819960
Eligibility Criteria:
Inclusion Criteria:
* signed written informed consent
* age \> 18 years
* histologically proven colorectal cancer patients starting new line of chemotherapy based on irinotecan
* ECOG PS 0 - 1 at study entry
* life expectancy more than 3 months
* absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule;
Exclusion Criteria:
* impossibility to take oral medication
* active infection treated by antibiotic therapy
* ileostoma
* hypersensitivity to study drug
* any concurrent malignancy other than non-melanoma skin cancer, no other cancer in past 5 years.
* serious concomitant systemic disorders or diseases incompatible with the study (at the discretion of investigator )
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02819960
Study Brief:
Protocol Section:
NCT02819960